Vol. 2 No. 3 (2019): “The Clinical Utility of Haptoglobin to Creatinine Ratio as a Test for Detecting Nephropathy among Type 2 Diabetic Patients”
“The Clinical Utility of Haptoglobin to Creatinine Ratio as a Test for Detecting Nephropathy among Type 2 Diabetic Patients”

Editorial Preface

You are welcome to yet another issue of the Journal of Biomedical Research and Clinical Practice. This package goes with the title: “The Clinical Utility of Haptoglobin to Creatinine Ratio as a Test for Detecting Nephropathy among Type 2 Diabetic Patients”. The authors assessed the clinical utility of urine Albumin to Creatinine ratio (UACR) and urine Haptoglobin to Creatinine ratio (UHCR) in detecting nephropathy among type 2 diabetic patients. This is against the backdrop of the sustained increase in cases of diabetic nephropathy and the need to provide easy diagnostic tools for its detection and early management. The authors found out that urine Haptoglobin to Creatinine ratio was a good marker for detecting nephropathy in diabetic patients. An overview of findings of lumbosacral Magnetic Resonance Imaging (MRI) among patients presenting with lumbosacral conditions at a University Hospital was similarly studied. The authors found out that degenerative disc disease was the most common finding, followed by lumbar spondylosis, and degenerative disc disease with exit nerve root compression while Lumbar fracture was the least common finding. Management of lumbosacral morbidities could greatly be enhanced by physicians practicing in settings where these cutting-edge diagnostic techniques are unavailable by reading this research article. Feel free to explore the site for more interesting articles.

Professor Godwin T. Jombo
Editor-in-Chief